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A B S T R A C T
We report a case in which a recipient of a HeartWare1 HVAD left ventricular assist device (HeartWare,
Framingham, MA, USA) was unable to undergo standard outﬂow graft anastomosis to the ascending
aorta due to severe aortic calciﬁcation. The outﬂow graft of the device was instead anastomosed to the
descending aorta.
<Learning objective: Not all left ventricular assist device (LVAD) patients are candidates for outﬂow
graft anastomosis to the ascending aorta. We report a case in which a HeartWare LVAD outﬂow graft was
anastomosed to the descending aorta. We review this approach described in other contemporary devices
and animal models. We include reports on device explant and exchange.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Outﬂow graft anastomosis in contemporary left ventricular
assist devices (LVADs) is normally performed at the ascending
aorta. However, not all patients are candidates for this approach,
including those with severe ascending aortic calciﬁcation. An
alternative option for these patients may be to anastomose the
outﬂow cannula to the descending aorta, as illustrated in the
following report.
Case report
A 77-year-old male with ischemic cardiomyopathy presented
in cardiogenic shock and required urgent placement of a LVAD.
Due to a severely calciﬁed ascending aorta seen on pre-operative
imaging (Fig. 1), we decided against standard anastomosis of the
outﬂow graft to the ascending aorta. Instead, the decision was
made to proceed with a left thoracotomy and outﬂow graft
anastomosis to the descending thoracic aorta. We elected to use
the HeartWare1 HVAD (HeartWare, Framingham, MA, USA)
because of its miniaturized dimensions and ﬂexibility of outﬂow
graft path, allowing for safe implantation through nonsternotomy* Corresponding author at: Cardiovascular Division, Department of Medicine,
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patient’s post-operative course was uneventful except for a left
chest washout due to high chest tube output of blood. To avoid
excessive blood stasis at the aortic root, thus minimizing the
potential risk of aortic root and ascending aorta thrombus [1], we
decreased the device speed from 2700 RPM to 2500 RPM to allow
more blood ﬂow through the aorta via the aortic valve. The patient
has had no device complications after 26 months of follow-up.
Surgical approach to the case
General anesthesia was administered through a double-lumen
endotracheal tube. The patient was positioned in the right lateral
decubitus position. A left thoracotomy was made in the sixth
intercostal space (Fig. 2). The pericardial space was opened
anterior to the phrenic nerve, and the apex of the heart was
exposed. The lung was mobilized by dividing the inferior
pulmonary ligament. After systemic heparinization, the femoral
vein and artery were cannulated, and full cardiopulmonary bypass
(CBP) was initiated. The inﬂow cannula position was conﬁrmed
using transesophageal echocardiogram (TEE) guidance. The apical
sewing ring was implanted in the usual standard fashion using 2-0
Ethibond sutures with a Teﬂon felt. After coring the left ventricular
apex with the apical coring tool, the inﬂow cannula and HVAD
pump were secured adequately. The outﬂow graft was measured
and sewn to the descending aorta using a side-biting clamp with
continuous 4-0 Prolene suture (Fig. 3). Carbon dioxide was utilized
throughout the procedure as part of the de-airing process, and as reserved.
Fig. 1.
Computed tomography scan of the chest demonstrating a severely
calciﬁed ascending aorta.
Fig. 2.
Left thoracotomy in the 6th intercostal space exposing the apex of the
heart and the descending aorta.
Fig. 3.
HeartWare HVAD outﬂow cannula positioned toward the descending
thoracic aorta.
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airing. In addition, de-airing was conﬁrmed under TEE-guidance
after ventilation was resumed. The patient was weaned from CPB
and the HeartWare HVAD was initiated; total bypass time was
112 min. The driveline was tunneled out through a left upper
quadrant incision. Initial ﬂows were greater than 3.5–4 l/min.
Echocardiography showed mild to moderate LV decompression
and mild right ventricular dysfunction as well as 1:2 to 1:3 aortic
valve opening (aortic valve to cardiac beat ratio).
Discussion
Outﬂow graft anastomosis of the HeartWare1 HVAD device
is normally performed at the ascending aorta. At the time of
this report, only one other case in the literature described
a HeartWare outﬂow graft anastomosis to the descending aorta
[2]. The indication was for multiple prior sternotomies in a
bridge-to-transplant patient, and this current case gives a new
indication for a porcelain aorta and use as destination therapy.
Therefore, most of our understanding of this approach derives
from studies performed with the Jarvik 2000 LVAD (Jarvik Heart,
New York, NY, USA). Based upon computational ﬂow dynamics of
the Jarvik 2000, outﬂow graft anastomosis to the descending
aorta potentially risks aortic root thrombosis in the event of
75% device output due to immobile blood particles dwelling
upon a closed aortic valve [1]. In a calf animal model using the
Jarvik 2000 LVAD, placement of the outﬂow graft in either the
ascending aorta (n = 4) or the descending aorta (n = 4) did not
affect the device ability to unload the left ventricle. There was no
signiﬁcant difference in myocardial perfusion and oxygen
consumption, aortic pressure, heart rate, central venous pres-
sure, pump-ﬂow to total-cardiac-ﬂow ratio, or coronary artery
blood ﬂow at equivalent speed intervals [3]. The HeartWare
‘‘Lavare’’ Cycle, a feature that is currently not approved by the
US Food and Drug Administration, increases the amount of ﬂow
through the aortic valve by decreasing the device speed, allowing
less ﬂow through the pump and more through the aortic valve
[4]. The concept of changing pump speeds to facilitate aortic
valve opening was implemented in the Jarvik 2000, known as ILS
(intermittent low speed) mode.
There are few reports describing device explant or exchange in
patients who have undergone descending aorta anastomoses
with contemporary devices. Device explant occurs at the time of
heart transplant, which requires a median sternotomy. While a left
thoracotomy would be ideal for removal of the descending
aorta outﬂow graft, successful approaches to device explantation
through median sternotomy alone have been demonstrated,
ultimately decreasing perioperative morbidity. Banbury [5] de-
scribed opening the posterior pericardium and circumferential
dissection of the anastomosis site, followed by implementation of
a vascular stapler to provide closure despite the remains of an
outﬂow graft ‘‘stump.’’ Cohn et al. [6] described another approach for
device explantation at the time of transplant. To accomplish this
with median sternotomy alone, they had to leave behind an 8 cm
blind limb remnant of the Jarvik 2000 outﬂow graft attached to the
descending aorta. In their study of 18 patients that underwent this
approach, none had experienced distal emboli, pseudoaneurysm, or
graft infection after a 4.5-year follow-up period.
Device exchange may occur in the setting of device failure,
pump thrombosis, or infection. In the event of device exchange,
anastomosis of a new outﬂow graft to the remnant of the original
outﬂow graft is often performed, in which case a left thoracotomy
would be most appropriate in the setting of a previous descending
aorta anastomosis. Patency and free retrograde blood ﬂow should
be conﬁrmed. If a new anastomosis site is necessary, another
anastomosis site to the descending aorta would be necessary.
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In LVAD candidates who are ineligible to receive ascending
aortic cannulation with the outﬂow graft, anastomosis to the
descending aorta with HVAD may be a safe alternative approach.
Computation ﬂow models and animal studies may be necessary to
optimize clinical success with this approach.
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